Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology • Medical Oncology • Internal Medicine • Rheumatology • COVID-19 • Hematology • Pediatric Hematology • General Rheumatology • Infectious Disease
Do you recommend routine use of Evusheld for pre-exposure prophylaxis for patients on immunosuppression?
Does treatment with B-cell depletion and/or negative anti-spike antibody status despite COVID mRNA vaccination influence your decision?
Answer from: at Academic Institution
The use of monoclonal antibodies as passive immunity for pre-exposure prophylaxis is an exciting development for vulnerable patients, including immunosuppressed patients (either primary or through medications such as for autoimmune diseases), cancer patients, and organ transplant recipients.
Evushe...
Sign in or Register to read more